154 related articles for article (PubMed ID: 38228875)
1. A comparative study on riboflavin responsive multiple acyl-CoA dehydrogenation deficiency due to variants in FLAD1 and ETFDH gene.
Wen B; Tang R; Tang S; Sun Y; Xu J; Zhao D; Wang T; Yan C
J Hum Genet; 2024 Apr; 69(3-4):125-131. PubMed ID: 38228875
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Missaglia S; Tavian D; Moro L; Angelini C
Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
[TBL] [Abstract][Full Text] [Related]
3. Clinical, pathological and genetic features and follow-up of 110 patients with late-onset MADD: a single-center retrospective study.
Wen B; Tang S; Lv X; Li D; Xu J; Olsen RKJ; Zhao Y; Li W; Wang T; Shao K; Zhao D; Yan C
Hum Mol Genet; 2022 Mar; 31(7):1115-1129. PubMed ID: 34718578
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G>A.
Wang ZQ; Chen XJ; Murong SX; Wang N; Wu ZY
J Mol Med (Berl); 2011 Jun; 89(6):569-76. PubMed ID: 21347544
[TBL] [Abstract][Full Text] [Related]
5. Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations.
Wen B; Dai T; Li W; Zhao Y; Liu S; Zhang C; Li H; Wu J; Li D; Yan C
J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):231-6. PubMed ID: 19758981
[TBL] [Abstract][Full Text] [Related]
6. Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
Yıldız Y; Talim B; Haliloglu G; Topaloglu H; Akçören Z; Dursun A; Sivri HS; Coşkun T; Tokatlı A
Pediatr Neurol; 2019 Oct; 99():69-75. PubMed ID: 31331668
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Law LK; Tang NL; Hui J; Fung SL; Ruiter J; Wanders RJ; Fok TF; Lam CW
Clin Chim Acta; 2009 Jun; 404(2):95-9. PubMed ID: 19265687
[TBL] [Abstract][Full Text] [Related]
8. Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations.
Chen W; Zhang Y; Ni Y; Cai S; Zheng X; Mastaglia FL; Wu J
BMC Neurol; 2019 Dec; 19(1):330. PubMed ID: 31852447
[TBL] [Abstract][Full Text] [Related]
9. Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report.
Goh LL; Lee Y; Tan ES; Lim JSC; Lim CW; Dalan R
BMC Med Genomics; 2018 Apr; 11(1):37. PubMed ID: 29615056
[TBL] [Abstract][Full Text] [Related]
10. Significant clinical heterogeneity with similar ETFDH genotype in three Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency.
Fu HX; Liu XY; Wang ZQ; Jin M; Wang DN; He JJ; Lin MT; Wang N
Neurol Sci; 2016 Jul; 37(7):1099-105. PubMed ID: 27000805
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of a patient with late-onset multiple acyl-CoA dehydrogenase deficiency caused by novel mutations in ETFDH: A case report.
Wang J; Wu JC; Yu XE; Han YZ; Yang RM
Medicine (Baltimore); 2018 Nov; 97(48):e13153. PubMed ID: 30508893
[TBL] [Abstract][Full Text] [Related]
12. High resolution melting analysis facilitates mutation screening of ETFDH gene: applications in riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Er TK; Liang WC; Chang JG; Jong YJ
Clin Chim Acta; 2010 May; 411(9-10):690-9. PubMed ID: 20138856
[TBL] [Abstract][Full Text] [Related]
13. Flavin adenine dinucleotide synthase deficiency due to FLAD1 mutation presenting as multiple acyl-CoA dehydrogenation deficiency-like disease: A case report.
Yamada K; Ito M; Kobayashi H; Hasegawa Y; Fukuda S; Yamaguchi S; Taketani T
Brain Dev; 2019 Aug; 41(7):638-642. PubMed ID: 30982706
[TBL] [Abstract][Full Text] [Related]
14. ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
Liang WC; Ohkuma A; Hayashi YK; López LC; Hirano M; Nonaka I; Noguchi S; Chen LH; Jong YJ; Nishino I
Neuromuscul Disord; 2009 Mar; 19(3):212-6. PubMed ID: 19249206
[TBL] [Abstract][Full Text] [Related]
15. Skin damage in a patient with lipid storage myopathy with a novel ETFDH mutation responsive to riboflavin.
Xu H; Chen X; Lian Y; Wang S; Ji T; Zhang L; Li S
Int J Neurosci; 2020 Dec; 130(12):1192-1198. PubMed ID: 32064983
[No Abstract] [Full Text] [Related]
16. Molecular and Clinical Investigations on Portuguese Patients with Multiple acyl-CoA Dehydrogenase Deficiency.
Henriques BJ; Lucas TG; Martins E; Gaspar A; Bandeira A; Nogueira C; Brandão O; Rocha H; Vilarinho L; Gomes CM
Curr Mol Med; 2019; 19(7):487-493. PubMed ID: 31418342
[TBL] [Abstract][Full Text] [Related]
17. Riboflavin-responsive lipid-storage myopathy in elderly patients.
Sadeh M; Dory A; Lev D; Yosovich K; Dabby R
J Neurol Sci; 2024 Jan; 456():122808. PubMed ID: 38043332
[TBL] [Abstract][Full Text] [Related]
18. Increased muscle coenzyme Q10 in riboflavin responsive MADD with ETFDH gene mutations due to secondary mitochondrial proliferation.
Wen B; Li D; Shan J; Liu S; Li W; Zhao Y; Lin P; Zheng J; Li D; Gong Y; Yan C
Mol Genet Metab; 2013 Jun; 109(2):154-60. PubMed ID: 23628458
[TBL] [Abstract][Full Text] [Related]
19. [Mutation analysis for a family affected with riboflavin responsive-multiple acyl-CoA dehydrogenase deficiency].
Lu J; Ji L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Aug; 31(4):428-32. PubMed ID: 25119904
[TBL] [Abstract][Full Text] [Related]
20. The clinical, pathological, and genetic characteristics of lipid storage myopathy in northern China.
Han J; Lu S; Song X; Jı G; Xıe Y; Wu H
Turk J Med Sci; 2022 Aug; 52(4):1256-1265. PubMed ID: 36326420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
